H1CA34

R$91.05

▼-4.11%

wb_incandescent Backtest

Stock

HCA Healthcare, Inc.

Official Company Name: HCA Healthcare, Inc.

Stock Symbol: H1CA34

Stock Market: B3 - Bovespa

Currency: Brazilian real - BRL

business HCA Healthcare, Inc. Company Profile

H1CA34 Stock Price - 1 Year Price Evolution & Moving Averages

1 Year Return

▲+38.23%

file_download

Daily closing prices, with moving averages and volumes - Brazilian real (BRL)
Moving averages:

  • EMA20
  • SMA50
  • SMA200

Company Description

HCA Healthcare is a company operating hospitals and health care facilities in the United States and the United Kingdom. Owning and managing more than 180 hospitals and 2,000 health care facilities, such as surgery centers, freestanding emergency rooms, urgent care centers, and physician clinics, HCA Healthcare is also involved in clinical research and has been named one of the world’s most ethical companies.

business HCA Healthcare, Inc. Company Profile

H1CA34 Stock Data

Open R$91.05
High R$91.05
Low R$91.05
Close R$91.05
Volume 750
Previous Close R$94.95
1-Day Change -3.90
1-Year Change 25.18
Average Daily Volume 640
52-Week High R$118.40
52-Week Low R$65.38
warning

Disclaimer

All information and data available on Disfold is NOT FINANCIAL ADVICE. Invest at your own risk!

Past performance is not a guarantee of future performance. Patterns tend to repeat themselves, but they don't necessarily have to.

Successful backtests on past data do not guarantee the future success of the strategy backtested, especially as backtest overfitting may occur: when the price of a stock may fit particularly well a given trading strategy over a given period, but not necessarily outside of that period. Besides, backtests do not account for exact market conditions and may yield significantly different results in real trading practice (fees, slippage...).

Furthermore, even though Disfold strives to provide the best and most accurate data, errors can occur in Disfold's systems, or in our data providers' systems.

Please conduct your own due diligence to verify insights.